Nathan D. Seligson, Nathan D. Seligson, Nathan D. Seligson, Xunjie Zhang, Mark C. Zemanek, Jasmine A. Johnson, . . . Ming J. Poi. (2024). CYP3A5 influences oral tacrolimus pharmacokinetics and timing of acute kidney injury following allogeneic hematopoietic stem cell transplantation. Frontiers Media S.A..
Chicago Style (17th ed.) CitationNathan D. Seligson, et al. CYP3A5 Influences Oral Tacrolimus Pharmacokinetics and Timing of Acute Kidney Injury Following Allogeneic Hematopoietic Stem Cell Transplantation. Frontiers Media S.A., 2024.
MLA (9th ed.) CitationNathan D. Seligson, et al. CYP3A5 Influences Oral Tacrolimus Pharmacokinetics and Timing of Acute Kidney Injury Following Allogeneic Hematopoietic Stem Cell Transplantation. Frontiers Media S.A., 2024.
Warning: These citations may not always be 100% accurate.